Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Grafting: Results of the EXPEDITION Study-Reference-Cited by-同舟云学术

Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Grafting: Results of the EXPEDITION Study

Published:2008-04 Issue:4 Volume:85 Page:1261-1270
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Mentzer Robert M.,Bartels Claus,Bolli Roberto,Boyce Steven,Buckberg Gerald D.,Chaitman Bernard,Haverich Axel,Knight John,Menasché Philippe,Myers M. Lee,Nicolau Jose,Simoons Maarten,Thulin Lars,Weisel Richard D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference31 articles.

1. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery;Jones;J Am Coll Cardiol,1996

2. Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting;Tomic;Circulation,2005

3. Myocardial protection at a crossroads;Bolli;Circulation,2004

4. Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection;Mentzer;Ann Thorac Surg,2003

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Na+/H+-exchange inhibition by cariporide is compensated via Na+,HCO3−-cotransport and has no net growth consequences for ErbB2-driven breast carcinomas;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions;American Journal of Physiology-Cell Physiology;2024-09-01

3. Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2;Basic Research in Cardiology;2024-07-24

4. Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?;Current Hypertension Reports;2024-06-24

5. Myocardial protection in cardiac surgery: a comprehensive review of current therapies and future cardioprotective strategies;Frontiers in Medicine;2024-06-19